Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2016-01-12
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antimicrobial Hernia Repair Device Clinical Study
NCT02401334
Observational Study to Evaluate Ventral Incisional Hernia Repair Using a Biologic Mesh (Cook Biodesign)
NCT02129140
Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer
NCT00647569
A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation
NCT01305486
Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias
NCT02691962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antimicrobial Hernia Repair Device
Antimicrobial hernia repair device for repair of ventral or incisional hernias in Class II and III surgical fields.
Antimicrobial Hernia Repair Device
hernia repair
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antimicrobial Hernia Repair Device
hernia repair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unwilling or unable to sign and date the informed consent
* Pregnant, breastfeeding, or planning to become pregnant prior to completing the study
* Unable or unwilling to comply with follow-up schedule
* Simultaneously participating in another investigational drug or device study.
* Medical condition or disorder that would limit life expectancy to less than the primary clinical study endpoint.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.